Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooke E Howitt

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Oncotarget|February 13, 2016
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerKyle C Strickland, Brooke E Howitt, Sachet A Shukla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 12, 2016
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CAJaclyn C Watkins, Brooke E Howitt, Neil S Horowitz, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Marisa R Nucci, Fleur Webster, Sabrina Croce, et al.
Gynecologic Oncology|December 17, 2013
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutationsJames R Conner, Emily Meserve, Ellen Pizer, et al.
Journal of the American College of Surgeons|December 27, 2016
Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid CancerMichael C Sullivan, Paul H Graham, Erik K Alexander, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 25, 2016
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like SyndromeJaclyn C Watkins, Eric J Yang, Michael G Muto, et al.
Nature Immunology|August 23, 2024
Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancerChristine Yiwen Yeh, Karmen Aguirre, Olivia Laveroni, et al.
Histopathology|August 22, 2024
STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for STK11 adnexal tumoursAmir Dehghani, Aarti E Sharma, Stephanie E Siegmund, et al.
The American Journal of Surgical Pathology|May 23, 2024
Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous ComponentsPhoebe M Hammer, Aihui Wang, Lisa Vermij, et al.
The American Journal of Surgical Pathology|April 3, 2026
GLI1-Rearranged Tumors of the gynaecologic Tract: A Detailed Clinicopathologic Study of 10 CasesRoman E Zyla, Brooke E Howitt, Tjalling Bosse, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Oncotarget|February 13, 2016
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerKyle C Strickland, Brooke E Howitt, Sachet A Shukla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 12, 2016
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CAJaclyn C Watkins, Brooke E Howitt, Neil S Horowitz, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Marisa R Nucci, Fleur Webster, Sabrina Croce, et al.
Gynecologic Oncology|December 17, 2013
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutationsJames R Conner, Emily Meserve, Ellen Pizer, et al.
Journal of the American College of Surgeons|December 27, 2016
Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid CancerMichael C Sullivan, Paul H Graham, Erik K Alexander, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 25, 2016
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like SyndromeJaclyn C Watkins, Eric J Yang, Michael G Muto, et al.
Nature Immunology|August 23, 2024
Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancerChristine Yiwen Yeh, Karmen Aguirre, Olivia Laveroni, et al.
Histopathology|August 22, 2024
STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for STK11 adnexal tumoursAmir Dehghani, Aarti E Sharma, Stephanie E Siegmund, et al.
The American Journal of Surgical Pathology|May 23, 2024
Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous ComponentsPhoebe M Hammer, Aihui Wang, Lisa Vermij, et al.
The American Journal of Surgical Pathology|April 3, 2026
GLI1-Rearranged Tumors of the gynaecologic Tract: A Detailed Clinicopathologic Study of 10 CasesRoman E Zyla, Brooke E Howitt, Tjalling Bosse, et al.
Pageof 17